rodio pharma limited
rodio pharma limited Company Information
Company Number
12395232
Next Accounts
Sep 2025
Shareholders
juno pharmaceuticals lp
graham fraser-pye
View AllGroup Structure
View All
Industry
Other business support service activities n.e.c.
Registered Address
cannon place 78 cannon street, london, EC4N 6AF
Website
-rodio pharma limited Estimated Valuation
Pomanda estimates the enterprise value of RODIO PHARMA LIMITED at £0 based on a Turnover of £0 and 0.54x industry multiple (adjusted for size and gross margin).
rodio pharma limited Estimated Valuation
Pomanda estimates the enterprise value of RODIO PHARMA LIMITED at £0 based on an EBITDA of £-6.3k and a 3.95x industry multiple (adjusted for size and gross margin).
rodio pharma limited Estimated Valuation
Pomanda estimates the enterprise value of RODIO PHARMA LIMITED at £0 based on Net Assets of £-400.8k and 2.13x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Rodio Pharma Limited Overview
Rodio Pharma Limited is a live company located in london, EC4N 6AF with a Companies House number of 12395232. It operates in the other business support service activities n.e.c. sector, SIC Code 82990. Founded in January 2020, it's largest shareholder is juno pharmaceuticals lp with a 35.5% stake. Rodio Pharma Limited is a young, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Rodio Pharma Limited Health Check
There is insufficient data available to calculate a health check for Rodio Pharma Limited. Company Health Check FAQs
0 Strong
0 Regular
2 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Rodio Pharma Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Rodio Pharma Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- Rodio Pharma Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Rodio Pharma Limited
- - Industry AVG
Employees
There is insufficient data available for this Key Performance Indicator!
- - Rodio Pharma Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Rodio Pharma Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Rodio Pharma Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Rodio Pharma Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Rodio Pharma Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Rodio Pharma Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (22 weeks)
- - Rodio Pharma Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 56628.1%, this is a higher level of debt than the average (62.5%)
- - Rodio Pharma Limited
- - Industry AVG
RODIO PHARMA LIMITED financials
Rodio Pharma Limited's latest turnover from December 2023 is estimated at 0 and the company has net assets of -£400.8 thousand. According to their latest financial statements, we estimate that Rodio Pharma Limited has no employees and maintains cash reserves of £609 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|
| Turnover | ||||
| Other Income Or Grants | ||||
| Cost Of Sales | ||||
| Gross Profit | ||||
| Admin Expenses | ||||
| Operating Profit | ||||
| Interest Payable | ||||
| Interest Receivable | ||||
| Pre-Tax Profit | ||||
| Tax | ||||
| Profit After Tax | ||||
| Dividends Paid | ||||
| Retained Profit | ||||
| Employee Costs | ||||
| Number Of Employees | ||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|
| Tangible Assets | ||||
| Intangible Assets | ||||
| Investments & Other | ||||
| Debtors (Due After 1 year) | ||||
| Total Fixed Assets | ||||
| Stock & work in progress | ||||
| Trade Debtors | ||||
| Group Debtors | ||||
| Misc Debtors | 100 | 100 | 100 | 6,984 |
| Cash | 609 | 1,017 | 428 | |
| misc current assets | ||||
| total current assets | 709 | 1,117 | 528 | 6,984 |
| total assets | 709 | 1,117 | 528 | 6,984 |
| Bank overdraft | ||||
| Bank loan | ||||
| Trade Creditors | ||||
| Group/Directors Accounts | 1,922 | |||
| other short term finances | ||||
| hp & lease commitments | ||||
| other current liabilities | 401,493 | 395,645 | 361,838 | 7,758 |
| total current liabilities | 401,493 | 395,645 | 361,838 | 9,680 |
| loans | 354,886 | |||
| hp & lease commitments | ||||
| Accruals and Deferred Income | ||||
| other liabilities | ||||
| provisions | ||||
| total long term liabilities | 354,886 | |||
| total liabilities | 401,493 | 395,645 | 361,838 | 364,566 |
| net assets | -400,784 | -394,528 | -361,310 | -357,582 |
| total shareholders funds | -400,784 | -394,528 | -361,310 | -357,582 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|
| Operating Activities | ||||
| Operating Profit | ||||
| Depreciation | ||||
| Amortisation | ||||
| Tax | ||||
| Stock | ||||
| Debtors | -6,884 | 6,984 | ||
| Creditors | ||||
| Accruals and Deferred Income | 5,848 | 33,807 | 354,080 | 7,758 |
| Deferred Taxes & Provisions | ||||
| Cash flow from operations | ||||
| Investing Activities | ||||
| capital expenditure | ||||
| Change in Investments | ||||
| cash flow from investments | ||||
| Financing Activities | ||||
| Bank loans | ||||
| Group/Directors Accounts | -1,922 | 1,922 | ||
| Other Short Term Loans | ||||
| Long term loans | -354,886 | 354,886 | ||
| Hire Purchase and Lease Commitments | ||||
| other long term liabilities | ||||
| share issue | ||||
| interest | ||||
| cash flow from financing | ||||
| cash and cash equivalents | ||||
| cash | -408 | 589 | 428 | |
| overdraft | ||||
| change in cash | -408 | 589 | 428 |
rodio pharma limited Credit Report and Business Information
Rodio Pharma Limited Competitor Analysis
Perform a competitor analysis for rodio pharma limited by selecting its closest rivals, whether from the ADMINISTRATIVE AND SUPPORT SERVICE ACTIVITIES sector, other young companies, companies in EC4N area or any other competitors across 12 key performance metrics.
rodio pharma limited Ownership
RODIO PHARMA LIMITED group structure
Rodio Pharma Limited has no subsidiary companies.
Ultimate parent company
RODIO PHARMA LIMITED
12395232
rodio pharma limited directors
Rodio Pharma Limited currently has 6 directors. The longest serving directors include Mr Mark Roberts (Jan 2020) and Mr Craig Podolsky (Jan 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Mark Roberts | United Kingdom | 57 years | Jan 2020 | - | Director |
| Mr Craig Podolsky | England | 44 years | Jan 2020 | - | Director |
| Mr Craig Podolsky | United Kingdom | 44 years | Jan 2020 | - | Director |
| Mr Graham Fraser-Pye | United Kingdom | 57 years | Jan 2020 | - | Director |
| Mr Graham Fraser-Pye | England | 57 years | Jan 2020 | - | Director |
| Mr Graham Fraser-Pye | England | 57 years | Jan 2020 | - | Director |
P&L
December 2023turnover
0
0%
operating profit
-6.3k
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
-400.8k
+0.02%
total assets
709
-0.37%
cash
609
-0.4%
net assets
Total assets minus all liabilities
rodio pharma limited company details
company number
12395232
Type
Private limited with Share Capital
industry
82990 - Other business support service activities n.e.c.
incorporation date
January 2020
age
5
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2023
previous names
N/A
accountant
TC GROUP
auditor
-
address
cannon place 78 cannon street, london, EC4N 6AF
Bank
-
Legal Advisor
-
rodio pharma limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to rodio pharma limited.
rodio pharma limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for RODIO PHARMA LIMITED. This can take several minutes, an email will notify you when this has completed.
rodio pharma limited Companies House Filings - See Documents
| date | description | view/download |
|---|
